Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD.
作者信息
Bunting Kevin D, Xie Xiu Yan, Warshawsky Ilka, Hsi Eric D
出版信息
Blood. 2007 Oct 1;110(7):2775-6. doi: 10.1182/blood-2007-05-090969.
Abstract
摘要
相似文献
1
Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD.
Blood. 2007 Oct 1;110(7):2775-6. doi: 10.1182/blood-2007-05-090969.
2
Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD.
Blood. 2006 Aug 15;108(4):1339-45. doi: 10.1182/blood-2005-11-011429. Epub 2006 Apr 20.
3
FLT3-ITD expression levels and their effect on STAT5 in AML with and without NPM mutations.
Br J Haematol. 2009 Dec;147(5):653-61. doi: 10.1111/j.1365-2141.2009.07901.x. Epub 2009 Sep 22.
4
Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to ITD mutations.
Elife. 2016 Nov 23;5:e18882. doi: 10.7554/eLife.18882.
5
FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia.
Oncotarget. 2015 Apr 20;6(11):9189-205. doi: 10.18632/oncotarget.3279.
6
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
Oncotarget. 2016 Mar 1;7(9):9964-74. doi: 10.18632/oncotarget.7128.
7
SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML.
Blood. 2012 Apr 26;119(17):4026-33. doi: 10.1182/blood-2011-07-365726. Epub 2012 Mar 12.
8
The FLT3-ITD mutation and the expression of its downstream signaling intermediates STAT5 and Pim-1 are positively correlated with CXCR4 expression in patients with acute myeloid leukemia.
Sci Rep. 2019 Aug 21;9(1):12209. doi: 10.1038/s41598-019-48687-z.
9
The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.
Acta Pharmacol Sin. 2015 Mar;36(3):385-99. doi: 10.1038/aps.2014.142. Epub 2015 Feb 2.
10
CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Oncotarget. 2015 Nov 10;6(35):38061-78. doi: 10.18632/oncotarget.5706.
引用本文的文献
1
STAT5 is Expressed in CD34/CD38 Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Cancers (Basel). 2020 Apr 21;12(4):1021. doi: 10.3390/cancers12041021.
2
A rapid method for quantifying cytoplasmic versus nuclear localization in endogenous peripheral blood leukocytes by conventional flow cytometry.
Cytometry A. 2017 Apr;91(4):351-363. doi: 10.1002/cyto.a.23103. Epub 2017 Mar 30.
3
STAT5 in hematopoietic stem cell biology and transplantation.
JAKSTAT. 2013 Oct 1;2(4):e27159. doi: 10.4161/jkst.27159. Epub 2013 Nov 19.
4
Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
J Histochem Cytochem. 2009 Jul;57(7):701-8. doi: 10.1369/jhc.2009.953547. Epub 2009 Mar 30.
5
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.
Blood. 2008 Sep 15;112(6):2463-73. doi: 10.1182/blood-2007-09-115477. Epub 2008 Jun 25.
6
The different functions of Stat5 and chromatin alteration through Stat5 proteins.
Front Biosci. 2008 May 1;13:6237-54. doi: 10.2741/3151.
本文引用的文献
1
Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
Am J Surg Pathol. 2007 Feb;31(2):233-9. doi: 10.1097/01.pas.0000213338.25111.d3.
2
Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors.
J Cell Biol. 2006 Dec 18;175(6):937-46. doi: 10.1083/jcb.200604073.
3
Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias.
Blood. 2007 Feb 15;109(4):1678-86. doi: 10.1182/blood-2006-01-029918. Epub 2006 Oct 12.
4
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18962-7. doi: 10.1073/pnas.0509714102. Epub 2005 Dec 19.
5
Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
J Clin Oncol. 2004 Jun 1;22(11):2053-60. doi: 10.1200/JCO.2004.11.046.
6
Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications.
Leuk Res. 2003 Sep;27(9):803-5. doi: 10.1016/s0145-2126(03)00012-2.
Zotero 插件